CAS 4502-00-5: Sodium α-ketoisocaproate

Sodium alpha-ketoisocaproate is a sodium salt that is used as a protein synthesis inhibitor. It blocks the formation of the amino acid glutamine, which is required for protein synthesis. Sodium alpha-ketoisocaproate has been shown to inhibit the growth of liver cells in vitro. This inhibition may be due to its ability to bind with fatty acids and form an acid complex that inhibits cell growth. This drug also has an inhibitory effect on corynebacterium glutamicum, an organism that can cause abdominal surgery infections, and other bacteria such as Staphylococcus aureus and Enterobacter cloacae. The production of urea nitrogen was inhibited by 50% in mice given this drug for three days before surgery. Sodium alpha-ketoisocaproate is also active against Escherichia coli, Salmonella enterica serovar Typhimurium, Klebsiella pneumoniae, Proteus mirabil

4-Methyl-2-oxovalerate is an L-leucine precursor/metabolite and a key compound in 2-methylpropyl glucosinolate synthesis and diabetes marker.

Stability Hygroscopic Applications 4-Methyl-2-oxovaleric Acid is an α-ketomonocarboxylic acid that triggers insulin release by acting upon receptor sites which differ from those occupied by amino acids. 4-Methyl-2-oxovaleric Acid is an intermediate in the metabolism of Leucine. References Panten, U. et al.: Naun.-Schmied. Arch. Pharmacol., 291, 405 (1975); Vague, P. et al.: Diab. Metab., 1, 185 (1975); Francois, G. et al.: Lancet, 1, 858 (1984);

4-Methyl-2-oxopentanoic acid sodium salt